Influence of castration and BMT on the development of EAE for days 0 to 42 after disease induction
| . | EAE alone . | EAE BMT alone . | EAE Cx & BMT . |
|---|---|---|---|
| Disease incidence | 30/31 | 38/43 | 37/43 |
| Day of disease onset | 10.5 (8-18) | 13.8 (8-54) | 13.0 (8-30) |
| Death of severe disease | 0/31 (0%) | 3/43 (7%) | 0/43 (0 %) |
| Maximum clinical score | 2.7 ± 0.6 | 2.2 ± 1.2 | 1.8 ± 1.4 |
| Cumulative clinical score | 62.0 ± 20.3 | 32.38 ± 27.7† | 18.54 ± 15.7*† |
| Duration of disease, d | 30.5 ± 4.9 | 17.3 ± 10.7† | 12.9 ± 10.6† |
| . | EAE alone . | EAE BMT alone . | EAE Cx & BMT . |
|---|---|---|---|
| Disease incidence | 30/31 | 38/43 | 37/43 |
| Day of disease onset | 10.5 (8-18) | 13.8 (8-54) | 13.0 (8-30) |
| Death of severe disease | 0/31 (0%) | 3/43 (7%) | 0/43 (0 %) |
| Maximum clinical score | 2.7 ± 0.6 | 2.2 ± 1.2 | 1.8 ± 1.4 |
| Cumulative clinical score | 62.0 ± 20.3 | 32.38 ± 27.7† | 18.54 ± 15.7*† |
| Duration of disease, d | 30.5 ± 4.9 | 17.3 ± 10.7† | 12.9 ± 10.6† |